Alloimmunosensitization in left ventricular assist device recipients and impact on posttransplantation outcome

Marian Urban, Tomas Gazdic, Eva Slimackova, Jan Pirk, Ondrej Szarszoi, Jiri Maly, Ivan Netuka

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Left ventricular assist devices (LVADs) have become an established surgical therapy for patients with end-stage heart failure who require hemodynamic support as a bridge-to-transplant or destination therapy. However, the anatomic and physiologic consequences of long-term LVAD support have yet to be fully clarified. Despite the clinical success of these devices, it has been reported that many patients bridged to transplantation with mechanical support develop circulating antibodies with potential donor reactivity. Transplanting against existing or historic donor-specific antibodies is associated with increased risk of antibody-mediated rejection, graft dysfunction, and decreased survival. Safe transplantation of allosensitized patients is dependent on using prospective crossmatching and antibody titer reduction techniques (desensitization). Strict protocols requiring a negative prospective crossmatch before transplantation result in a decreased donor pool and a longer duration of support in sensitized LVAD recipients with increased inherent morbidity such as infections and thromboembolic complications. The aim of this review is to present the current state of knowledge of possible immunologic mechanisms involved in alloimmunization of LVAD recipients, outline new methods of antibody detection, compare various desensitization strategies, and present an overview of clinical data assessing the impact of sensitization on posttransplantation outcome.

Original languageEnglish (US)
Pages (from-to)554-561
Number of pages8
JournalASAIO Journal
Volume58
Issue number6
DOIs
StatePublished - Nov 1 2012

Fingerprint

Left ventricular assist devices
Heart-Assist Devices
Antibodies
Transplantation
Tissue Donors
Transplantation (surgical)
Transplants
Graft Rejection
Hemodynamics
Grafts
Heart Failure
Morbidity
Equipment and Supplies
Survival
Therapeutics
Infection

Keywords

  • heart
  • left ventricular assist device
  • mechanical support
  • sensitization
  • transplantation

ASJC Scopus subject areas

  • Biophysics
  • Bioengineering
  • Biomaterials
  • Biomedical Engineering

Cite this

Alloimmunosensitization in left ventricular assist device recipients and impact on posttransplantation outcome. / Urban, Marian; Gazdic, Tomas; Slimackova, Eva; Pirk, Jan; Szarszoi, Ondrej; Maly, Jiri; Netuka, Ivan.

In: ASAIO Journal, Vol. 58, No. 6, 01.11.2012, p. 554-561.

Research output: Contribution to journalArticle

Urban, Marian ; Gazdic, Tomas ; Slimackova, Eva ; Pirk, Jan ; Szarszoi, Ondrej ; Maly, Jiri ; Netuka, Ivan. / Alloimmunosensitization in left ventricular assist device recipients and impact on posttransplantation outcome. In: ASAIO Journal. 2012 ; Vol. 58, No. 6. pp. 554-561.
@article{8d1d0fa9adbb44c6b8b37029a13b88bd,
title = "Alloimmunosensitization in left ventricular assist device recipients and impact on posttransplantation outcome",
abstract = "Left ventricular assist devices (LVADs) have become an established surgical therapy for patients with end-stage heart failure who require hemodynamic support as a bridge-to-transplant or destination therapy. However, the anatomic and physiologic consequences of long-term LVAD support have yet to be fully clarified. Despite the clinical success of these devices, it has been reported that many patients bridged to transplantation with mechanical support develop circulating antibodies with potential donor reactivity. Transplanting against existing or historic donor-specific antibodies is associated with increased risk of antibody-mediated rejection, graft dysfunction, and decreased survival. Safe transplantation of allosensitized patients is dependent on using prospective crossmatching and antibody titer reduction techniques (desensitization). Strict protocols requiring a negative prospective crossmatch before transplantation result in a decreased donor pool and a longer duration of support in sensitized LVAD recipients with increased inherent morbidity such as infections and thromboembolic complications. The aim of this review is to present the current state of knowledge of possible immunologic mechanisms involved in alloimmunization of LVAD recipients, outline new methods of antibody detection, compare various desensitization strategies, and present an overview of clinical data assessing the impact of sensitization on posttransplantation outcome.",
keywords = "heart, left ventricular assist device, mechanical support, sensitization, transplantation",
author = "Marian Urban and Tomas Gazdic and Eva Slimackova and Jan Pirk and Ondrej Szarszoi and Jiri Maly and Ivan Netuka",
year = "2012",
month = "11",
day = "1",
doi = "10.1097/MAT.0b013e31826d6070",
language = "English (US)",
volume = "58",
pages = "554--561",
journal = "ASAIO Journal",
issn = "1058-2916",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Alloimmunosensitization in left ventricular assist device recipients and impact on posttransplantation outcome

AU - Urban, Marian

AU - Gazdic, Tomas

AU - Slimackova, Eva

AU - Pirk, Jan

AU - Szarszoi, Ondrej

AU - Maly, Jiri

AU - Netuka, Ivan

PY - 2012/11/1

Y1 - 2012/11/1

N2 - Left ventricular assist devices (LVADs) have become an established surgical therapy for patients with end-stage heart failure who require hemodynamic support as a bridge-to-transplant or destination therapy. However, the anatomic and physiologic consequences of long-term LVAD support have yet to be fully clarified. Despite the clinical success of these devices, it has been reported that many patients bridged to transplantation with mechanical support develop circulating antibodies with potential donor reactivity. Transplanting against existing or historic donor-specific antibodies is associated with increased risk of antibody-mediated rejection, graft dysfunction, and decreased survival. Safe transplantation of allosensitized patients is dependent on using prospective crossmatching and antibody titer reduction techniques (desensitization). Strict protocols requiring a negative prospective crossmatch before transplantation result in a decreased donor pool and a longer duration of support in sensitized LVAD recipients with increased inherent morbidity such as infections and thromboembolic complications. The aim of this review is to present the current state of knowledge of possible immunologic mechanisms involved in alloimmunization of LVAD recipients, outline new methods of antibody detection, compare various desensitization strategies, and present an overview of clinical data assessing the impact of sensitization on posttransplantation outcome.

AB - Left ventricular assist devices (LVADs) have become an established surgical therapy for patients with end-stage heart failure who require hemodynamic support as a bridge-to-transplant or destination therapy. However, the anatomic and physiologic consequences of long-term LVAD support have yet to be fully clarified. Despite the clinical success of these devices, it has been reported that many patients bridged to transplantation with mechanical support develop circulating antibodies with potential donor reactivity. Transplanting against existing or historic donor-specific antibodies is associated with increased risk of antibody-mediated rejection, graft dysfunction, and decreased survival. Safe transplantation of allosensitized patients is dependent on using prospective crossmatching and antibody titer reduction techniques (desensitization). Strict protocols requiring a negative prospective crossmatch before transplantation result in a decreased donor pool and a longer duration of support in sensitized LVAD recipients with increased inherent morbidity such as infections and thromboembolic complications. The aim of this review is to present the current state of knowledge of possible immunologic mechanisms involved in alloimmunization of LVAD recipients, outline new methods of antibody detection, compare various desensitization strategies, and present an overview of clinical data assessing the impact of sensitization on posttransplantation outcome.

KW - heart

KW - left ventricular assist device

KW - mechanical support

KW - sensitization

KW - transplantation

UR - http://www.scopus.com/inward/record.url?scp=84868635890&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84868635890&partnerID=8YFLogxK

U2 - 10.1097/MAT.0b013e31826d6070

DO - 10.1097/MAT.0b013e31826d6070

M3 - Article

VL - 58

SP - 554

EP - 561

JO - ASAIO Journal

JF - ASAIO Journal

SN - 1058-2916

IS - 6

ER -